Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Buelow

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Genomewide Screen Identifies Peroxisomal Role in APOL1 PodocytopathyJiyoung Kim, Isaac Z Karel, Huijuan Song, et al.
Kidney International|June 17, 2026
Genome-wide Screen Identifies Peroxisomal Role in APOL1 PodocytopathyJiyoung Kim, Isaac Z Karel, Huijuan Song, et al.
Investigational New Drugs|May 19, 2019
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AMLJae Yoon Jeon, Qiuhong Zhao, Daelynn R Buelow, et al.
The Journal of Clinical Investigation|December 12, 2017
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemiaJolieke G van Oosterwijk, Daelynn R Buelow, Christina D Drenberg, et al.
Journal of Clinical Microbiology|January 11, 2013
PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogensChristian Massire, Daelynn R Buelow, Sean X Zhang, et al.
Nature Communications|May 18, 2019
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AMLChristina D Drenberg, Anang Shelat, Jinjun Dang, et al.
Blood Advances|August 21, 2023
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology studyBhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, et al.
The Journal of Clinical Investigation|December 10, 1999
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injuryF Amersi, R Buelow, H Kato, et al.
Molecular Cancer Therapeutics|September 14, 2021
Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD-Positive AMLMegan E Zavorka Thomas, Xiyuan Lu, Zahra Talebi, et al.
Clinical and Translational Science|July 28, 2019
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AMLDaelynn R Buelow, Stanley B Pounds, Yong-Dong Wang, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Genomewide Screen Identifies Peroxisomal Role in APOL1 PodocytopathyJiyoung Kim, Isaac Z Karel, Huijuan Song, et al.
Kidney International|June 17, 2026
Genome-wide Screen Identifies Peroxisomal Role in APOL1 PodocytopathyJiyoung Kim, Isaac Z Karel, Huijuan Song, et al.
Investigational New Drugs|May 19, 2019
Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AMLJae Yoon Jeon, Qiuhong Zhao, Daelynn R Buelow, et al.
The Journal of Clinical Investigation|December 12, 2017
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemiaJolieke G van Oosterwijk, Daelynn R Buelow, Christina D Drenberg, et al.
Journal of Clinical Microbiology|January 11, 2013
PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogensChristian Massire, Daelynn R Buelow, Sean X Zhang, et al.
Nature Communications|May 18, 2019
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AMLChristina D Drenberg, Anang Shelat, Jinjun Dang, et al.
Blood Advances|August 21, 2023
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology studyBhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, et al.
The Journal of Clinical Investigation|December 10, 1999
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injuryF Amersi, R Buelow, H Kato, et al.
Molecular Cancer Therapeutics|September 14, 2021
Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD-Positive AMLMegan E Zavorka Thomas, Xiyuan Lu, Zahra Talebi, et al.
Clinical and Translational Science|July 28, 2019
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AMLDaelynn R Buelow, Stanley B Pounds, Yong-Dong Wang, et al.
Pageof 12